A final decision from EMA is expected soon. Please note that Novo Nordisk’s once-weekly subcutaneous diabetes injection, Ozempic, is already approved in 0.25 mg, 0.5 mg, 1 mg and 2 mg doses for ...
Results that may be inaccessible to you are currently showing.